Applied Genetic Technologies Corporation
AGTC
AGTC was delisted on the 30th of November, 2022.
65 hedge funds and large institutions have $90.6M invested in Applied Genetic Technologies Corporation in 2020 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 22 increasing their positions, 10 reducing their positions, and 14 closing their positions.
1,610% more call options, than puts
Call options by funds: $1.8M | Put options by funds: $105K
120% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 10
84% more capital invested
Capital invested by funds: $49.3M → $90.6M (+$41.3M)
50% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 14
10% more funds holding
Funds holding: 59 → 65 (+6)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$5.31M |
| 2 |
CCPM
Cooper Creek Partners Management
New York
|
+$4.42M |
| 3 |
State Street
Boston,
Massachusetts
|
+$1.48M |
| 4 |
PCM
Portolan Capital Management
Boston,
Massachusetts
|
+$1.42M |
| 5 |
Millennium Management
New York
|
+$830K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$1.93M |
| 2 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$1.92M |
| 3 |
GTC
Ghost Tree Capital
New York
|
-$1.22M |
| 4 |
Russell Investments Group
London,
United Kingdom
|
-$1.21M |
| 5 |
Renaissance Technologies
New York
|
-$808K |
AGTC Hedge Fund Activity: Q2 2020 in Review
65 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Applied Genetic Technologies Corporation (AGTC) for Q2 2020, worth a combined $90.6M — up 84% from $49.3M a quarter earlier.
Buyers outnumbered sellers: 21 funds opened new AGTC positions and 14 closed out — a net gain of 7 holders — while 22 added to existing stakes and 10 trimmed.
The largest buyer was BlackRock, adding an estimated $5.31M. The largest seller was Stonepine Capital Management, exiting entirely with an estimated $1.93M sold.
- 65 institutional investors held Applied Genetic Technologies Corporation (AGTC) as of Q2 2020, up from 59 in Q1 2020.
- Funds reported $90.6M of Applied Genetic Technologies Corporation stock for Q2 2020, up 84% quarter-over-quarter.
- 21 funds opened new Applied Genetic Technologies Corporation positions in Q2 2020 and 14 closed out, a net change of +7 holders.
- The largest Applied Genetic Technologies Corporation buyer in Q2 2020 was BlackRock, an estimated $5.31M added.
- The largest Applied Genetic Technologies Corporation seller in Q2 2020 was Stonepine Capital Management, an estimated $1.93M sold.
Based on aggregated 13F filings for Q2 2020.